ALPS Advisors’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $89.7K | Sell |
|
|||||
|
2024
Q4 | $98.5K | Buy |
|
|||||
|
2024
Q3 | $166K | Sell |
|
|||||
|
2024
Q2 | $214K | Buy |
|
|||||
|
2024
Q1 | $261K | Buy |
|
|||||
|
2023
Q4 | $137K | Sell |
|
|||||
|
2023
Q3 | $173K | Buy |
|
|||||
|
2023
Q2 | $331K | Buy |
|
|||||
|
2023
Q1 | $556K | Sell |
|
|||||
|
2022
Q4 | $655K | Buy |
|
|||||
|
2022
Q3 | $585K | Sell |
|
|||||
|
2022
Q2 | $581K | Sell |
|
|||||
|
2022
Q1 | $1.5M | Sell |
|
|||||
|
2021
Q4 | $1.76M | Sell |
|
|||||
|
2021
Q3 | $1.41M | Sell |
|
|||||
|
2021
Q2 | $1.17M | Sell |
|
|||||
|
2021
Q1 | $1.79M | Buy |
|
|||||
|
2020
Q4 | $1.53M | Buy |
|
|||||
|
2020
Q3 | $1.17M | Sell |
|
|||||
|
2020
Q2 | $1.37M | Sell |
|
|||||
|
2020
Q1 | $1.84M | Sell |
|
|||||
|
2019
Q4 | $2.46M | Buy |
|
|||||
|
2019
Q3 | $2.36M | Sell |
|
|||||
|
2019
Q2 | $3.77M | Sell |
|
|||||
|
2019
Q1 | $4.86M | Buy |
|
|||||
|
2018
Q4 | $3.53M | Buy |
|
|||||
|
2018
Q3 | $3.39M | Buy |
|
|||||
|
2018
Q2 | $3.84M | Buy |
|
|||||
|
2018
Q1 | $2.53M | Buy |
|
|||||
|
2017
Q4 | $1.24M | Buy |
|
|||||
|
2017
Q3 | $877K | Buy |
|
|||||
|
2017
Q2 | $618K | Buy |
|
|||||
|
2017
Q1 | $504K | Sell |
|
|||||
|
2016
Q4 | $1.22M | Sell |
|
|||||
|
2016
Q3 | $1.12M | Buy |
|
|||||
|
2016
Q2 | $910K | Buy |
|
|||||
|
2016
Q1 | $1.09M | Buy |
|
|||||
|
2015
Q4 | $1.21M | Sell |
|
|||||
|
2015
Q3 | $14.9K | Buy |
|
|||||
|
2015
Q2 | $1.52M | Buy |
|
|||||
|
2015
Q1 | $746K | Buy |
|
|||||
|
2014
Q4 | $690K | Sell |
|
|||||
|
2014
Q3 | $590K | Buy |
|